Arthroscopy tech assessment
This article was originally published in The Gray Sheet
Executive Summary
CMS will determine by Jan. 8 the indications for which arthroscopic lavage and/or debridement are "reasonable and necessary" for treating osteoarthritis of the knee, based on a review of data published in The New England Journal of Medicine suggesting the procedures are no more effective than placebo (1"The Gray Sheet" Sept. 2, 2002, p. 6). In early December, the Veterans Administration plans to release an internal review of whether recent study findings warrant limited coverage of the procedure...
You may also be interested in...
VA Reviewing Coverage Of Arthroscopic Knee Surgery; NEJM Study Debated
The Veterans Administration plans to complete within the next 90 days an internal review of whether recent study findings warrant continued coverage of arthroscopic knee surgical procedures to alleviate pain and stiffness caused by osteoarthritis
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.